This third issue of GaBI Journal is the last of the volume for this year and marks the end of the first year of me taking up the Editor-in Chief position for the Journal. We have seen a very considerable variety of papers submitted and published during 2024.

The first Review Article in this issue by Dr Shivani Mittra et al. is titled ‘Aligning environmental, social, and governance to clinical development: moving towards more sustainable clinical trials’. These authors point out that drug development is among the highest producers of greenhouse gas emissions with clinical trials being the main culprit. They consider that there is an urgent requirement to develop tools capable of measuring the carbon footprint of clinical trials and guidelines on how to reduce it. The comprehensive article discusses how regulators, pharmaceutical companies, and clinical researchers can align with the environmental, social, and governance goals for the efficient conduct of clinical trials, including those for biologicals and biosimilars.

Subscribe now to GaBI Journal to view full information of GaBI Journal published manuscripts.

This manuscript has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record.